Gilead Sciences, Inc. (GILD)
149.61
-0.31
(-0.21%)
USD |
NASDAQ |
Sep 02, 16:00
149.61
0.00 (0.00%)
After-Hours: 16:07
Gilead Sciences Cash from Operations (TTM) : 13.55B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.55B |
| March 31, 2026 | 10.81B |
| December 31, 2025 | 10.02B |
| September 30, 2025 | 9.667B |
| June 30, 2025 | 9.868B |
| March 31, 2025 | 10.37B |
| December 31, 2024 | 10.83B |
| September 30, 2024 | 10.02B |
| June 30, 2024 | 7.468B |
| March 31, 2024 | 8.48B |
| December 31, 2023 | 8.006B |
| September 30, 2023 | 8.404B |
| June 30, 2023 | 9.512B |
| March 31, 2023 | 8.977B |
| December 31, 2022 | 9.072B |
| September 30, 2022 | 9.71B |
| June 30, 2022 | 10.10B |
| March 31, 2022 | 10.61B |
| December 31, 2021 | 11.38B |
| September 30, 2021 | 10.10B |
| June 30, 2021 | 9.092B |
| March 31, 2021 | 9.342B |
| December 31, 2020 | 8.168B |
| September 30, 2020 | 8.832B |
| June 30, 2020 | 9.481B |
| Date | Value |
|---|---|
| March 31, 2020 | 9.136B |
| December 31, 2019 | 9.144B |
| September 30, 2019 | 8.909B |
| June 30, 2019 | 8.222B |
| March 31, 2019 | 7.574B |
| December 31, 2018 | 8.40B |
| September 30, 2018 | 8.808B |
| June 30, 2018 | 9.29B |
| March 31, 2018 | 11.24B |
| December 31, 2017 | 11.90B |
| September 30, 2017 | 13.01B |
| June 30, 2017 | 14.64B |
| March 31, 2017 | 15.84B |
| December 31, 2016 | 17.05B |
| September 30, 2016 | 18.06B |
| June 30, 2016 | 17.82B |
| March 31, 2016 | 18.76B |
| December 31, 2015 | 20.33B |
| September 30, 2015 | 18.48B |
| June 30, 2015 | 18.42B |
| March 31, 2015 | 16.95B |
| December 31, 2014 | 12.82B |
| September 30, 2014 | 10.52B |
| June 30, 2014 | 7.233B |
| March 31, 2014 | 4.001B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.293B |
| AbbVie, Inc. | 19.51B |
| Regeneron Pharmaceuticals, Inc. | 4.681B |
| Amgen, Inc. | 12.48B |
| Biogen, Inc. | 2.879B |